Stefan E. Pool

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Determinants of diagnostic yield and scan quality of [18F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin.

Determinants of diagnostic yield and scan quality of [18F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin.

Journal: Critical care (London, England)

Published: January 22, 2026

Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications.

Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: September 08, 2023

Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.

Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 10, 2015

[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.

[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: May 14, 2014

Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

Journal: EJNMMI research

Published: February 06, 2014

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments.

Journal: Clinical and translational imaging

Published: November 08, 2013

mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.

mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.

Journal: Cancer research

Published: November 15, 2012

Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.

Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.

Journal: Molecular imaging

Published: March 16, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026